{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T12:02:49Z","timestamp":1784203369207,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Genet"],"DOI":"10.1038\/s10038-025-01362-w","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T01:05:12Z","timestamp":1751418312000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Approaches to diagnostic screening for congenital disorders of glycosylation and its prevalence in Japan"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5415-656X","authenticated-orcid":false,"given":"Nobuhiko","family":"Okamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Machiko","family":"Kadoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinao","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"1362_CR1","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/0009-8981(84)90059-7","volume":"144","author":"J Jaeken","year":"1984","unstructured":"Jaeken J, van Eijk HG, van der Heul C, Corbeel L, Eeckels R, Eggermont E. Sialic acid-deficient serum and cerebrospinal fluid transferrin in a newly recognized genetic syndrome. Clin Chim Acta. 1984;144:245\u20137. https:\/\/doi.org\/10.1016\/0009-8981(84)90059-7.","journal-title":"Clin Chim Acta"},{"key":"1362_CR2","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/ng0597-88","volume":"16","author":"G Matthijs","year":"1997","unstructured":"Matthijs G, Schollen E, Pardon E, Veiga-Da-Cunha M, Jaeken J, Cassiman JJ, et al. Mutations in PMM2, a phosphomannomutase gene on chromosome 16p13, in carbohydrate-deficient glycoprotein type I syndrome (Jaeken syndrome). Nat Genet. 1997;16:88\u201392. https:\/\/doi.org\/10.1038\/ng0597-88.","journal-title":"Nat Genet"},{"key":"1362_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/jimd.12024","volume":"42","author":"R Altassan","year":"2019","unstructured":"Altassan R, P\u00e9anne R, Jaeken J, Barone R, Bidet M, Borgel D, et al. International clinical guidelines for the management of phosphomannomutase 2-congenital disorders of glycosylation: diagnosis, treatment and follow up. J Inherit Metab Dis. 2019;42:5\u201328. https:\/\/doi.org\/10.1002\/jimd.12024.","journal-title":"J Inherit Metab Dis"},{"key":"1362_CR4","doi-asserted-by":"publisher","first-page":"108476","DOI":"10.1016\/j.ymgme.2024.108476","volume":"142","author":"BG Ng","year":"2024","unstructured":"Ng BG, Freeze HH, Himmelreich N, Blau N, Ferreira CR. Clinical and biochemical footprints of congenital disorders of glycosylation: proposed nosology. Mol Genet Metab. 2024;142:108476. https:\/\/doi.org\/10.1016\/j.ymgme.2024.108476.","journal-title":"Mol Genet Metab"},{"key":"1362_CR5","doi-asserted-by":"publisher","first-page":"e70011","DOI":"10.1002\/jmd2.70011","volume":"66","author":"N Okamoto","year":"2025","unstructured":"Okamoto N, Kadoya M, Wada Y. Clinical and molecular features of patients with congenital disorders of glycosylation in Japan. JIMD Rep. 2025;66:e70011. https:\/\/doi.org\/10.1002\/jmd2.70011.","journal-title":"JIMD Rep"},{"key":"1362_CR6","doi-asserted-by":"publisher","first-page":"107606","DOI":"10.1016\/j.ymgme.2023.107606","volume":"139","author":"D De Graef","year":"2023","unstructured":"De Graef D, Ligezka AN, Rezents J, Mazza GL, Preston G, Schwartz K, et al. Coagulation abnormalities in a prospective cohort of 50 patients with PMM2-congenital disorder of glycosylation. Mol Genet Metab. 2023;139:107606. https:\/\/doi.org\/10.1016\/j.ymgme.2023.107606.","journal-title":"Mol Genet Metab"},{"key":"1362_CR7","doi-asserted-by":"publisher","first-page":"e12826","DOI":"10.1002\/jimd.12826","volume":"48","author":"V Holubova","year":"2025","unstructured":"Holubova V, Barone R, Grunewald S, Tesa\u0159ov\u00e1 M, Hans\u00edkov\u00e1 H, August\u00ednov\u00e1 J, et al. Clinical severity and cardiac phenotype in phosphomannomutase 2-congenital disorders of glycosylation: insights into genetics and management recommendations. J Inherit Metab Dis. 2025;48:e12826. https:\/\/doi.org\/10.1002\/jimd.12826.","journal-title":"J Inherit Metab Dis"},{"key":"1362_CR8","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/s0387-7604(12)80276-2","volume":"14","author":"K Ohno","year":"1992","unstructured":"Ohno K, Yuasa I, Akaboshi S, Itoh M, Yoshida K, Ehara H, et al. The carbohydrate deficient glycoprotein syndrome in three Japanese children. Brain Dev. 1992;14:30\u20135. https:\/\/doi.org\/10.1016\/s0387-7604(12)80276-2.","journal-title":"Brain Dev"},{"key":"1362_CR9","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/0006-291x(92)92278-6","volume":"189","author":"Y Wada","year":"1992","unstructured":"Wada Y, Nishikawa A, Okamoto N, Inui K, Tsukamoto H, Okada S, et al. Structure of serum transferrin in carbohydrate-deficient glycoprotein syndrome. Biochem Biophys Res Commun. 1992;189:832\u20136. https:\/\/doi.org\/10.1016\/0006-291x(92)92278-6.","journal-title":"Biochem Biophys Res Commun"},{"key":"1362_CR10","doi-asserted-by":"publisher","first-page":"A0104","DOI":"10.5702\/massspectrometry.A0104","volume":"11","author":"Y Wada","year":"2022","unstructured":"Wada Y, Okamoto N. Electrospray ionization mass spectrometry of Apolipoprotein CIII to evaluate O-glycan site occupancy and sialylation in congenital disorders of glycosylation. Mass Spectrom. 2022;11:A0104. https:\/\/doi.org\/10.5702\/massspectrometry.A0104.","journal-title":"Mass Spectrom"},{"key":"1362_CR11","doi-asserted-by":"publisher","first-page":"A0103","DOI":"10.5702\/massspectrometry.A0103","volume":"11","author":"Y Wada","year":"2022","unstructured":"Wada Y, Okamoto N. Electrospray ionization mass spectrometry of transferrin: use of quadrupole mass analyzers for congenital disorders of glycosylation. Mass Spectrom. 2022;11:A0103. https:\/\/doi.org\/10.5702\/massspectrometry.A0103.","journal-title":"Mass Spectrom"},{"key":"1362_CR12","doi-asserted-by":"publisher","first-page":"A0113","DOI":"10.5702\/massspectrometry.A0113","volume":"11","author":"Y Wada","year":"2022","unstructured":"Wada Y, Kadoya M, Okamoto N. Mass spectrometry of transferrin and Apolipoprotein CIII from dried blood spots for congenital disorders of glycosylation. Mass Spectrom. 2022;11:A0113. https:\/\/doi.org\/10.5702\/massspectrometry.A0113.","journal-title":"Mass Spectrom"},{"key":"1362_CR13","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1093\/glycob\/cws086","volume":"22","author":"Y Wada","year":"2012","unstructured":"Wada Y, Kadoya M, Okamoto N. Mass spectrometry of apolipoprotein C-III, a simple analytical method for mucin-type O-glycosylation and its application to an autosomal recessive cutis laxa type-2 (ARCL2) patient. Glycobiology. 2012;22:1140\u20134. https:\/\/doi.org\/10.1093\/glycob\/cws086.","journal-title":"Glycobiology"},{"key":"1362_CR14","doi-asserted-by":"publisher","first-page":"e4597","DOI":"10.1002\/jms.4597","volume":"56","author":"Y Wada","year":"2021","unstructured":"Wada Y, Okamoto N. Apolipoprotein C-III O-glycoform profiling of 500 serum samples by matrix-assisted laser desorption\/ionization mass spectrometry for diagnosis of congenital disorders of glycosylation. J Mass Spectrom. 2021;56:e4597. https:\/\/doi.org\/10.1002\/jms.4597.","journal-title":"J Mass Spectrom"},{"key":"1362_CR15","doi-asserted-by":"publisher","first-page":"A0169","DOI":"10.5702\/massspectrometry.A0169","volume":"14","author":"Y Wada","year":"2025","unstructured":"Wada Y. Mass spectrometry as a first-line diagnostic aid for congenital disorders of glycosylation. Mass Spectrom. 2025;14:A0169. https:\/\/doi.org\/10.5702\/massspectrometry.A0169.","journal-title":"Mass Spectrom"},{"key":"1362_CR16","doi-asserted-by":"publisher","first-page":"8813121","DOI":"10.1155\/2024\/8813121","volume":"2024","author":"S Pajusalu","year":"2024","unstructured":"Pajusalu S, Vals MA, Serrano M, Witters P, Cechova A, Honzik T, et al. Genotype\/phenotype relationship: lessons from 137 patients with PMM2-CDG. Hum Mutat. 2024;2024:8813121. https:\/\/doi.org\/10.1155\/2024\/8813121.","journal-title":"Hum Mutat"},{"key":"1362_CR17","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s10038-022-01025-0","volume":"67","author":"Y Takahashi","year":"2022","unstructured":"Takahashi Y, Date H, Oi H, Adachi T, Imanishi N, Kimura E, et al. Six years\u2019 accomplishment of the initiative on rare and undiagnosed diseases: nationwide project in Japan to discover causes, mechanisms, and cures. J Hum Genet. 2022;67:505\u201313. https:\/\/doi.org\/10.1038\/s10038-022-01025-0.","journal-title":"J Hum Genet"},{"key":"1362_CR18","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/sj.ejhg.5200470","volume":"8","author":"E Schollen","year":"2000","unstructured":"Schollen E, Kjaergaard S, Legius E, Schwartz M, Matthijs G. Lack of Hardy-Weinberg equilibrium for the most prevalent PMM2 mutation in CDG-Ia (congenital disorders of glycosylation type Ia). Eur J Hum Genet. 2000;8:367\u201371. https:\/\/doi.org\/10.1038\/sj.ejhg.5200470.","journal-title":"Eur J Hum Genet"},{"key":"1362_CR19","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jpeds.2016.12.060","volume":"183","author":"C P\u00e9rez-Cerd\u00e1","year":"2017","unstructured":"P\u00e9rez-Cerd\u00e1 C, Gir\u00f3s ML, Serrano M, Ecay MJ, Gort L, P\u00e9rez Due\u00f1as B, et al. Population-based study on congenital disorders of protein N- and combined with O-glycosylation experience in clinical and genetic diagnosis. J Pediatr. 2017;183:170\u20137.e1. https:\/\/doi.org\/10.1016\/j.jpeds.2016.12.060.","journal-title":"J Pediatr"},{"key":"1362_CR20","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/s41390-018-0206-6","volume":"84","author":"CG Asteggiano","year":"2018","unstructured":"Asteggiano CG, Papazoglu M, Bistu\u00e9 Mill\u00f3n MB, Peralta MF, Azar NB, Sp\u00e9cola NS, et al. Ten years of screening for congenital disorders of glycosylation in Argentina: case studies and pitfalls. Pediatr Res. 2018;84:837\u201341. https:\/\/doi.org\/10.1038\/s41390-018-0206-6.","journal-title":"Pediatr Res"},{"key":"1362_CR21","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jpeds.2020.12.026","volume":"231","author":"D Quelhas","year":"2021","unstructured":"Quelhas D, Martins E, Azevedo L, Bandeira A, Diogo L, Garcia P, et al. Congenital disorders of glycosylation in Portugal\u2014two decades of experience. J Pediatr. 2021;231:148\u201356. https:\/\/doi.org\/10.1016\/j.jpeds.2020.12.026.","journal-title":"J Pediatr"},{"key":"1362_CR22","doi-asserted-by":"publisher","first-page":"100726","DOI":"10.1016\/j.ymgmr.2021.100726","volume":"27","author":"P Lipi\u0144ski","year":"2021","unstructured":"Lipi\u0144ski P, Bogda\u0144ska A, Tylki-Szyma\u0144ska A. Congenital disorders of glycosylation: prevalence, incidence and mutational spectrum in the Polish population. Mol Genet Metab Rep. 2021;27:100726. https:\/\/doi.org\/10.1016\/j.ymgmr.2021.100726.","journal-title":"Mol Genet Metab Rep"},{"key":"1362_CR23","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3390\/brainsci11010088","volume":"11","author":"J Paprocka","year":"2021","unstructured":"Paprocka J, Jezela-Stanek A, Tylki-Szyma\u0144ska A, Grunewald S. Congenital disorders of glycosylation from a neurological perspective. Brain Sci. 2021;11:88. https:\/\/doi.org\/10.3390\/brainsci11010088.","journal-title":"Brain Sci"},{"key":"1362_CR24","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.3390\/genes12081227","volume":"12","author":"G Silver","year":"2021","unstructured":"Silver G, Bahl S, Cordeiro D, Thakral A, Athey T, Mercimek-Andrews S. Prevalence of congenital disorders of glycosylation in childhood epilepsy and effects of anti-epileptic drugs on the transferrin isoelectric focusing test. Genes. 2021;12:1227. https:\/\/doi.org\/10.3390\/genes12081227.","journal-title":"Genes"},{"key":"1362_CR25","doi-asserted-by":"publisher","first-page":"735348","DOI":"10.3389\/fgene.2021.735348","volume":"12","author":"JH Park","year":"2021","unstructured":"Park JH, Marquardt T. Treatment options in congenital disorders of glycosylation. Front Genet. 2021;12:735348. https:\/\/doi.org\/10.3389\/fgene.2021.735348.","journal-title":"Front Genet"},{"key":"1362_CR26","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/s41436-020-0767-8","volume":"22","author":"P Witters","year":"2020","unstructured":"Witters P, Tahata S, Barone R, \u00d5unap K, Salvarinova R, Gr\u00f8nborg S, et al. Clinical and biochemical improvement with galactose supplementation in SLC35A2-CDG. Genet Med. 2020;22:1102\u20137. https:\/\/doi.org\/10.1038\/s41436-020-0767-8.","journal-title":"Genet Med"},{"key":"1362_CR27","doi-asserted-by":"publisher","first-page":"dmm040584","DOI":"10.1242\/dmm.040584","volume":"12","author":"S Iyer","year":"2019","unstructured":"Iyer S, Sam FS, DiPrimio N, Preston G, Verheijen J, Murthy K, et al. Repurposing the aldose reductase inhibitor and diabetic neuropathy drug epalrestat for the congenital disorder of glycosylation PMM2-CDG. Dis Model Mech. 2019;12:dmm040584. https:\/\/doi.org\/10.1242\/dmm.040584.","journal-title":"Dis Model Mech"},{"key":"1362_CR28","doi-asserted-by":"publisher","first-page":"108487","DOI":"10.1016\/j.ymgme.2024.108487","volume":"142","author":"R Budhraja","year":"2024","unstructured":"Budhraja R, Radenkovic S, Jain A, Muffels IJJ, Ismaili MHA, Kozicz T, et al. Liposome-encapsulated mannose-1-phosphate therapy improves global N-glycosylation in different congenital disorders of glycosylation. Mol Genet Metab. 2024;142:108487. https:\/\/doi.org\/10.1016\/j.ymgme.2024.108487.","journal-title":"Mol Genet Metab"},{"key":"1362_CR29","doi-asserted-by":"publisher","unstructured":"Zhong ML, Lai K. AAV-based gene replacement therapy prevents and halts manifestation of abnormal neurological phenotypes in a novel mouse model of PMM2-CDG. Gene Ther. 2025. https:\/\/doi.org\/10.1038\/s41434-025-00525-w.","DOI":"10.1038\/s41434-025-00525-w"},{"key":"1362_CR30","doi-asserted-by":"publisher","first-page":"e70011","DOI":"10.1002\/jimd.70011","volume":"48","author":"IJJ Muffels","year":"2025","unstructured":"Muffels IJJ, Kozicz T, Perlstein EO, Morava E. The therapeutic future for congenital disorders of glycosylation. J Inherit Metab Dis. 2025;48:e70011. https:\/\/doi.org\/10.1002\/jimd.70011.","journal-title":"J Inherit Metab Dis"}],"container-title":["Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s10038-025-01362-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s10038-025-01362-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s10038-025-01362-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T01:05:12Z","timestamp":1751418312000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s10038-025-01362-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":30,"alternative-id":["1362"],"URL":"https:\/\/doi.org\/10.1038\/s10038-025-01362-w","relation":{},"ISSN":["1434-5161","1435-232X"],"issn-type":[{"value":"1434-5161","type":"print"},{"value":"1435-232X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"30 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the institutional review board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The procedures in this study were performed in accordance with the ethical standards for medical research outlined in the Helsinki Declaration. Informed consent was obtained from all patients and\/or parents included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent"}}]}}